THI International Symposium on Cardiovascular Regenerative Medicine

October 5-6, 2018
THI International Symposium on Cardiovascular Regenerative Medicine


In these current landscapes of development of the field of clinical regenerative medicine it is important to share new findings, discuss and debate the state of the field in order to direct further development and build the framework for clinical implementation. This meeting will provide an important forum for these activities.

Unlike areas with known evidence-based knowledge, the field of clinical stem cell therapy is a nascent field in which most of the competence and performance issues are unestablished. The primary need for this educational activity is knowledge based. Both need for knowledge and application of knowledge to establish successful strategies in clinical regenerative medicine are the goals of this symposium.

This two-day symposium will include advanced lectures and dynamic case presentations from leaders in each field and the opportunity to interact with leaders in an intimate meeting format.

Our audience for this continuing medical education activity will include physicians and researchers with an interest in cardiovascular regenerative medicine.

Join Global Leaders in the Field of Clinical Regenerative Medicine & Stem Cell Therapy

Educational Objectives

  • Summarize the latest developments in clinical cell therapy
  • Evaluate the active participation in the regulatory approval process
  • Determine successful strategies for using the field of regenerative medicine found through new research


Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.